Quick contact
Head of Science and Research Division
Tel:+420 221 977 305
Deputy head of Science and Research Division
Tel:+420 221 977 648
Secretary
Tel:+420 221 977 144
Institute of Hematology and Blood Transfusion
Lacko, L.
Transport of sugars into human red blood cell ghosts
[year of publication 2012]
Hrabánek, J.; Jirásek, A.; Marinov, I.
Tranzitorní těžká pancytopenie předcházející akutní lymfatickou leukémii u dospělého
[year of publication 2006]
Fuchs, O.; Jonasova, A.; Neuwirtova, R.
Treatment by oral antineoplastic and immunomodulatory agent lenalidomide in myelodysplastic syndromes
[year of publication 2013]
Motycka, K.; Chudomel, V.; Bednar, M.; Bostik, P.
Treatment of C3H mice bearing solid gardner lymphosarcoma with vaccine prepared from corynebacterium parvum combined with methotrexate and alexan
[year of publication 2020]
Motyčka, K.; Souček, J.; Slavík, K.; Jirásek, J.E.; Jirásek, A.
Treatment of experimental mouse hemoblastosis: 1. effect of some new folic acid antimetabolites on cell transplanted leukemia in mice of akr strain
[year of publication 2012]
Motyčka, K.; Souček, J.; Slavík, K.
Treatment of experimental mouse hemoblastosis: 2. effect of long-term administration of some folic acid antagonist on mice of akr strain
[year of publication 2012]
Souček, J.; Šochman, V.; Motyčka, K.; Novotná, O.; Slavík, K.
Treatment of experimental mouse hemoblastosis: 3. chemotherapy of LAH VUFB leukemia with some 4-amino analogues of folic acid
[year of publication 2012]
Motyčka, K.; Souček, J.
Treatment of experimental mouse hemoblastosis: 4. therapy of leukemia L 14 AKR with drugs of demonstrated or potential cytostatic effects
[year of publication 2012]
Motyčka, K.; Souček, J.
Treatment of experimental mouse hemoblastosis: VII. time course of change in the frequency of mitoses of leukaemic leukocytes (L 14 AKR and LaH VUFB) after administration of methotrexate
[year of publication 2012]
Treatment of lymphoid and myeloid malignancies by immunomodulatory drugs
[year of publication 2018 ]
Lukasova, M.; Libansky, J.; Sedlackova, M.
Treatment of malignant lymphomas with combination of cytostatics
[year of publication 2018]
Treatment of myelodysplastic syndrome and acute myeloid leukemia by immunomodulatory and epigenetic drugs
[year of publication 2013 ]
Treatment of myeloid hematologic malignancies with isocitrate dehydrogenase mutations by inhibitors of this enzyme
[year of publication 2021]
Motycka, K.; Slavik, K.; Balcarova, A.; Cihar, R.; Spacek, P.; Kubin, M.
Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin
[year of publication 2019]
Pristoupil, T.I.; Fricova, V.; Kramlova, M.; Pristoupilova, K.; Vrana, M.; Ulrych, S.
Trends in exploitation of packed red blood cells
[year of publication 2011]
Kořínková, P.; Calda, P.
Trombocytopenie v těhotenství : diagnóza, patogeneza a léčba
[year of publication 2006]
Head of Science and Research Division
Tel:+420 221 977 305
Deputy head of Science and Research Division
Tel:+420 221 977 648
Secretary
Tel:+420 221 977 144
Ambulance
Mo – Fr:
7:00–18:00
Weekends:
9:00–13:00
Donors
Mo – Fr:
7:00–10:30
Visitors
Inpatient department
Mo – Fr:
13:00–18:00
ICU and Transplant unit
Mo – Fr:
14:00–17:00
Ústav hematologie a krevní transfuze
(Institute of Hematology and Blood Transfusion)
U Nemocnice 2094/1
128 00 Praha 2
The nearest underground station: Karlovo náměstí (line B)
The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)
The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)